Advances in Sepsis Diagnostics: the HostDx Sepsis Platform
Timothy Sweeney, MD, PhD, CEO, Inflammatix, United States
Premier Sponsors
Programs
6 May Advances in Prenatal Molecular Diagnostics
7-8 May Biomarkers for Immunotherapy
Advanced Diagnostics for Infectious Disease
Enabling Technologies for Circulating Biomarkers
8-9 May Companion Diagnostics for Immuno-Oncology
Point-of-Care Diagnostics
Clinical Applications of Circulating Biomarkers
Short Courses